TRANSMEDICS GROUP INC (TMDX:NASDAQ)
$71.3 0.56 (0.7916%)
Analysed TRANSMEDICS GROUP INC (TMDX:NASDAQ) News Sources
TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract
05-08-2026
yahoo.com
TransMedics (TMDX) Q2 2026 Earnings Call Transcript
11-08-2026
fool.com
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion
18-08-2026
marketbeat.com
TransMedics to Present at Upcoming September Investor Conferences
31-08-2026
yahoo.com
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
03-09-2026
yahoo.com
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
29-09-2026
fool.com
TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds
02-10-2026
yahoo.com
TransMedics Group (TMDX) Stock Looks Below Fair Value On Earnings
02-10-2026
yahoo.com
TransMedics Group (TMDX) Stock Looks Undervalued On Current Earnings
17-10-2026
yahoo.com
TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026
22-10-2026
yahoo.com
What is the current price of TRANSMEDICS GROUP INC (TMDX:NASDAQ)?
The current price of TRANSMEDICS GROUP INC (TMDX:NASDAQ) is $71.3.
TRANSMEDICS GROUP INC (TMDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRANSMEDICS GROUP INC (TMDX:NASDAQ) since the previous trading day is $0.56.
TRANSMEDICS GROUP INC (TMDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRANSMEDICS GROUP INC (TMDX:NASDAQ) since the previous trading day is 0.7916%.
What is the most recent average sentiment score for TRANSMEDICS GROUP INC (TMDX:NASDAQ)?
The most recent average sentiment score for TRANSMEDICS GROUP INC (TMDX:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for TRANSMEDICS GROUP INC (TMDX:NASDAQ)?
The most recent sentiment for TRANSMEDICS GROUP INC (TMDX:NASDAQ) is .
SEC-8K** Filing Available For TRANSMEDICS GROUP INC (TMDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.